- EmployersClarifies statutory coverage so employees who donate organs and their employers have a clear legal basis to use FMLA le…
- Potential benefitMay lower barriers to organ donation by assuring donors they can take protected leave for surgery and recovery, which c…
- Federal agenciesFor federal employees, substituting available leave under 5 U.S.C. 6327 for FMLA time could make donor leave paid rathe…
To amend the Family and Medical Leave Act of 1993 and title 5, United States Code, to clarify that organ donation surgery qualifies as a serious health condition.
Referred to the Committee on Education and Workforce, and in addition to the Committees on Oversight and Government Reform, and House Administration, for a period to be subsequent…
This bill amends the Family and Medical Leave Act (FMLA) and federal civil service leave law to explicitly state that organ donation surgery (including recovery from such surgery) qualifies as a "serious health condition." For private-sector employees it inserts that language into the statutory definition of serious health condition. For federal employees it makes the same definitional clarification and adds that an employee who uses part of the 12-week leave period to serve as an organ donor shall substitute, to the extent possible, any leave available under section 6327 for that portion.
Whether the clarification is sufficient or should be paired with paid leave/supports (progressive wants paid support; conservatives oppose expanding mandates).
Relative to its intended legislative type, this bill provides a clear, narrowly framed statutory amendment to include organ donation surgery (and recovery) as a qualifying 'serious health condition' under both private-sector FMLA and federal employee leave law, and it adds a substitution-of-leave sentence for federal employees.
This bill amends the Family and Medical Leave Act (FMLA) and federal civil service leave law to explicitly state that organ donation surgery (including recovery from such surgery) qualifies as a "serious health condition." For private-sector employees it inserts that language into the statutory definition of serious health condition.
For federal employees it makes the same definitional clarification and adds that an employee who uses part of the 12-week leave period to serve as an organ donor shall substitute, to the extent possible, any leave available under section 6327 for that portion.
The bill therefore clarifies coverage and provides a leave-substitution rule for federal employees who are organ donors.
On substance the bill is a narrow, technical clarification addressing an uncontroversial policy goal (supporting organ donors). It does not impose large costs or contentious mandates and could attract bipartisan support. Its ultimate fate will depend less on content and more on legislative calendar, committee prioritization, and procedural opportunities in each chamber.
Relative to its intended legislative type, this bill provides a clear, narrowly framed statutory amendment to include organ donation surgery (and recovery) as a qualifying 'serious health condition' under both private-sector FMLA and federal employee leave law, and it adds a substitution-of-leave sentence for federal employees. The textual edits are specific and well-integrated into existing statutory provisions.
Whether the clarification is sufficient or should be paired with paid leave/supports (progressive wants paid support; conservatives oppose expanding mandates).
Who stands to gain, and who may push back.
These are examples from the analysis, not a ranked list of the most-affected groups.
- EmployersPrivate employers may face increased leave usage and associated costs (wage replacement, temporary staffing or overtime…
- Federal agenciesFederal agencies may incur administrative and fiscal effects from documenting and managing substituted leave under 5 U.…
- EmployersEmployers could face additional recordkeeping, scheduling, and staffing burdens to accommodate donor leave and to verif…
Why the argument around this bill splits.
Whether the clarification is sufficient or should be paired with paid leave/supports (progressive wants paid support; conservatives oppose expanding mandates).
A mainstream progressive would likely view this bill positively as a narrow, rights-preserving clarification that protects people who donate organs from losing their jobs or being denied leave.
They would see it as removing an administrative barrier and a stigma that might deter living donors, and as consistent with protecting caregiving and health-related leave.
They would note, however, that the bill does not create universal paid leave for private-sector donors and might want stronger paid-leave provisions or supports for low-income donors.
A pragmatic centrist would generally support the bill as a narrowly tailored technical fix that reduces legal ambiguity without creating sweeping new entitlements.
They would appreciate the modest scope and the goal of protecting organ donors while being cautious about administrative impacts on small businesses and the need for clear implementation rules.
They would want clarity on verification, duration of coverage, and costs to employers, and may favor modest mitigations for small employers if problems arise.
A mainstream conservative would likely be cautiously skeptical.
While supporting organ donation as a social good, they would be concerned about expanding categories of federally-protected leave and the administrative/operational burden on employers.
They may view the bill as another incremental expansion of FMLA that could lead to leave abuse or productivity impacts without addressing the economic cost to businesses.
The path through Congress.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
On substance the bill is a narrow, technical clarification addressing an uncontroversial policy goal (supporting organ donors). It does not impose large costs or contentious mandates and could attract bipartisan support. Its ultimate fate will depend less on content and more on legislative calendar, committee prioritization, and procedural opportunities in each chamber.
- No cost estimate or Congressional Budget Office analysis is included in the text; the fiscal impact on the federal payroll (from increased substitution of paid leave) is unclear though likely modest.
- Practical interactions with existing FMLA regulations and employer verification/administration procedures are not detailed; implementation guidance from agencies (e.g., DOL) may be needed.
Recent votes on the bill.
No vote history yet
The bill has not accumulated any surfaced votes yet.
Go deeper than the headline read.
Whether the clarification is sufficient or should be paired with paid leave/supports (progressive wants paid support; conservatives oppose…
On substance the bill is a narrow, technical clarification addressing an uncontroversial policy goal (supporting organ donors). It does not…
Relative to its intended legislative type, this bill provides a clear, narrowly framed statutory amendment to include organ donation surgery (and recovery) as a qualifying 'serious health condition' under both private-s…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.